08.11.2014 Views

Here - American Geriatrics Society

Here - American Geriatrics Society

Here - American Geriatrics Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P OSTER<br />

A BSTRACTS<br />

been ruled out. It is then recommended that in patients who present<br />

with delirium, ammonia level should be considered as part of the<br />

workup especially if they have accompanying constipation.<br />

A4 Encore Presentation<br />

Delirious Because of Treatment: An Adverse Effect of Imipenem.<br />

B. L. Africa, 1,2 D. Carthen, 1,2 H. Arabelo. 1,2 1. <strong>Geriatrics</strong>, St. Luke’s<br />

Roosevelt Hospital Center, New York, NY; 2. Columbia University<br />

College of Physicians and Surgeons, New York, NY.<br />

The mainstay treatment of delirium is the reversal of the underlying<br />

cause. In the elderly population, this is often caused by an infection,<br />

for which antibiotics are initiated. However in this case, it was<br />

the antibiotic that led to the delirium.<br />

This is a case of a 91 year old woman with a history of chronic osteomyelitis<br />

from an infected hip implant, who was admitted due to<br />

weakness and lethargy. She was found to have a sinus tract in the left<br />

hip with draining fluid and a urinary tract infection. She was started<br />

on cefepime and vancomycin. On the subsequent day, her mental status<br />

and leukocytosis has improved. Fluid cultures taken from her hip<br />

grew Pseudomonas resistant to cefepime and thus imipenem was<br />

started. Two days later she was found to be lethargic. She was diagnosed<br />

that time with hypoactive delirium from the<br />

osteomyelitis/hardware infection. Orthopedic surgery was consulted<br />

for removal of her hip hardware; however she was deemed not a candidate<br />

for surgery. Her symptoms progressed and she became comatose.<br />

The family was informed regarding her poor prognosis. Subsequently,<br />

her antibiotics were stopped due to futility. Two days after<br />

stopping imipenem, she was awake and asking for food. Her condition<br />

continued to improve and she was then eventually discharged home.<br />

This case shows the clinical implication of an adverse effect of a<br />

medication. Hypoactive delirium although not a known side effect of<br />

imipenem, was observed in this particular case. This indicates the investigation<br />

of other underlying causes of delirium, in which antibiotics<br />

maybe one of them. There have been no known published articles<br />

relating hypoactive delirium due to imipenem. It may be<br />

worthwhile to investigate on this matter.<br />

A5<br />

Title: Multiple myeloma with spontaneous tumor lysis syndrome in<br />

an elderly patient; a rare entity.<br />

H. Chataut, M. Bednarczyk, M. Gorbien, M. Leiding, J. Olson.<br />

Division of <strong>Geriatrics</strong> Medicine and Palliative Medicine, RUSH<br />

University Medical Center, Chicago, IL.<br />

Purpose: To recognize complications especially tumor lysis<br />

which can be associated with multiple myeloma ( MM) in an elderly<br />

patient.<br />

Case Report: An 83 year old woman with history of coronary artery<br />

disease presented with fatigue, weakness and unintentional 15<br />

lbs weight loss over 3 months. She denied fever/chills, night sweats,<br />

bladder/bowel complaints, bleeding from any site. Physical exam revealed<br />

normal vital signs and unremarkable systemic exam. Laboratory<br />

analysis revealed Hb 6 g/dL with normal MCV, Platelet count<br />

48,000/dL creatinine 3.7 mg/dL, total protein 12.1g/dL with albumin<br />

2.4 g/dL, Calcium 10.6 mg/dL, LDH 346 U/dL. Serum protein electrophoresis<br />

showed monoclonal band. She was hydrated and transfused<br />

packed RBCs and a bone marrow biopsy showed sheets of<br />

plasma cells consisting of 70% of marrow cellularity. Bone survey revealed<br />

multiple lytic lesions in skull, humerus, mandible. Chemotherapy<br />

was being planned but in the interim the symptoms worsened and<br />

laboratory analysis showed worsening creatinine 4.8 mg/dL, uric acid<br />

13.9 meq/dL, phosphorus 6 meq/dL and potassium 5.3 meq/dL. She<br />

was started on aggressive hydration and rasburicase for presumed<br />

tumor lysis syndrome, which resulted in improvement in symptoms<br />

and laboratory parameters. Dexamethasone was added for MM. Further<br />

therapy is being planned as outpatient with bortezomib with<br />

very close follow-up.<br />

Discussion: The incidence of MM increases considerably with<br />

age. The number of geriatric patients with MM is expected to increase<br />

over time as a consequence of the increased life expectancy of the<br />

normal population, and management of these patients is likely to become<br />

particularly pertinent in coming years. MM in the elderly can be<br />

a therapeutic challenge. Acute tumor lysis syndrome is rarely observed<br />

in MM. The incidence is probably less than 1% of patients who<br />

are treated with intermediate or high-dose chemotherapy. It is only<br />

occasionally observed with dexamethasone or prednisone treatment.<br />

Few case reports exist of the same. Spontaneous tumor lysis syndrome,<br />

on the other hand, has not been reported in untreated<br />

myeloma. Our case is unique with spontaneous tumor lysis in a very<br />

elderly patient with new diagnosis of MM, rapidly declining performance<br />

status with co-morbidities, presenting a therapeutic challenge.<br />

A6<br />

A case of atypical Gastro-intestinal bleeding (GIB) in an elderly; not<br />

just diverticulosis.<br />

H. Chataut, 1 M. Bednarczyk, 1 M. Gorbien, 1 M. Leiding, 1 J. Olson, 1<br />

C. Teodoro, 1 R. Arora. 2 1. Department of Geriatric Medicine, RUSH<br />

university medical center, Chicago, IL; 2. Gastroenterology, Rush<br />

University Medical Center, Chicago, IL.<br />

Purpose: GIB may present with vague symptoms and can be fatal.<br />

Background: GIB that required multiple procedures along with<br />

octreotide.<br />

Method: Case report<br />

Case report: A 85 year old man with receiving aspirin and<br />

coumadin presented with confusion, hypotension, tachycardia, guaiac<br />

positive and Hgb 5 gm/dl, INR 2.2. After resuscitation emergent<br />

colonoscopy revealed diverticulosis, non bleeding angiodysplasia<br />

(AVMs) and colon full of blood up to cecum with no blood in the terminal<br />

ileum, suggesting colonic source for bleeding. EGD up to duodenum<br />

showed no evidence of recent or active bleeding. Patient’s<br />

Hgb continues to drop requiring 17 units of Packed RBC transfusion<br />

in 2 days. Technetium labeled RBC scan localized the bleeding to<br />

duodenum and jejunum. Enterescopy showed bleeding site in the<br />

duodenum at junction of bulb and second portion of duodenum along<br />

with non bleeding AVMs in small bowel. Bleeding site was treated<br />

with epinephrine and cauterization. This temporarily stopped the<br />

bleeding; however bleeding recurred in the following day. Then patient<br />

underwent visceral arteriogram and empiric embolization of<br />

gastroduodenal artery (GDA), superior rectal artery of inferior<br />

mesenteric artery (IMA). In the setting worsening GIB, patient had a<br />

trial of octreotide infusion along with pantoprazole intravenously.<br />

Octreotide inhibits gastric acid secretion and decreases splanchnic<br />

blood flow due to its vasoconstrictive effect. Thereafter, hemoglobin<br />

stabilized and patient recovered.<br />

Discussion: This is a complex case of GIB from multiple angiodysplasia<br />

concurrent with diverticulosis. Patient presented with<br />

hypovolemic shock from GI bleed, requiring multiple blood transfusions.<br />

Thus we can initially assume that GIB from a large and readily<br />

visible source. However, this was not the case. This presented a diagnostic<br />

dilemma, which necessitated multiple procedures. To conclude,<br />

a trial of octreotide was given in the context of worsening GIB. In this<br />

case, looking and targeting a specific lesion may not be the best therapeutic<br />

option. Thus we step back and treat the GI system with a<br />

medication that affects it at all levels. This clinical scenario is not uncommon<br />

since both occur in elderly patients. Octreotide has been<br />

shown to halt bleeding in cases of angiodysplasia and was successful<br />

in our patient.<br />

A7<br />

The four-year mystery diagnosis.<br />

M. Walker, D. A. Pasquale. UPMC, Pittsburgh, PA.<br />

Background:<br />

S18<br />

AGS 2012 ANNUAL MEETING

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!